Arsenal Completes BresMed Acquisition

Arsenal Capital Partners (“Arsenal”), a leading private equity firm investing in healthcare and specialty industrials companies, announced Wednesday the acquisition of BresMed Health Solutions (“BresMed”), a pioneer in providing health economic research, communications, and consulting services to the global pharmaceutical industry. The acquisition of BresMed is the first in a series of investments to form a new value demonstration company in the market access, health economics and outcomes research, patient preference, and real world evidence space that will transform the way medical advances reach the patients who need them. The new company will support biopharmaceutical clients with the strategy, evidence and communication tools to help maximize the value of their products, guiding healthcare stakeholders worldwide in difficult decisions about resource allocation and access to new therapies.

Read the full article: Arsenal Completes BresMed Acquisition //


Scroll to Top